Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Nefopam pharmacokinetics in patients with end-stage renal disease.

Mimoz O, Chauvet S, Grégoire N, Marchand S, Le Guern ME, Saleh A, Couet W, Debaene B, Levy RH.

Anesth Analg. 2010 Nov;111(5):1146-53. doi: 10.1213/ANE.0b013e3181f33488.

PMID:
20971961
2.

Effect of route of administration on the pharmacokinetic behavior of enantiomers of nefopam and desmethylnefopam.

Chawla J, Le Guern ME, Alquier C, Kalhorn TF, Levy RH.

Ther Drug Monit. 2003 Apr;25(2):203-10.

PMID:
12657915
3.

Comparative pharmacokinetics and pharmacodynamics of intravenous and oral nefopam in healthy volunteers.

Aymard G, Warot D, Démolis P, Giudicelli JF, Lechat P, Le Guern ME, Alquier C, Diquet B.

Pharmacol Toxicol. 2003 Jun;92(6):279-86.

PMID:
12787260
4.

Postoperative analgesia and early rehabilitation after total knee replacement: a comparison of continuous low-dose intravenous ketamine versus nefopam.

Aveline C, Gautier JF, Vautier P, Cognet F, Hetet HL, Attali JY, Leconte V, Leborgne P, Bonnet F.

Eur J Pain. 2009 Jul;13(6):613-9. doi: 10.1016/j.ejpain.2008.08.003. Epub 2008 Sep 14.

PMID:
18793861
5.

[Analgesic effect of continuous intravenous nefopam after urological surgery].

Merle JC, Vandroux D, Odin I, Dupuis JL, Bougault A, Mehaddi Y, Nathan N.

Ann Fr Anesth Reanim. 2005 Jan;24(1):13-8. French.

PMID:
15661459
6.

Effect of severe renal failure and haemodialysis on the pharmacokinetics of levosimendan and its metabolites.

Puttonen J, Kantele S, Kivikko M, Häkkinen S, Harjola VP, Koskinen P, Pentikäinen PJ.

Clin Pharmacokinet. 2007;46(3):235-46.

PMID:
17328582
8.

Randomized prospective study of the analgesic effect of nefopam after orthopaedic surgery.

Du Manoir B, Aubrun F, Langlois M, Le Guern ME, Alquier C, Chauvin M, Fletcher D.

Br J Anaesth. 2003 Dec;91(6):836-41.

PMID:
14633755
9.

[Nefopam by continuous intravenous injection and adverse drug reactions: which causality assessment?].

Ould-Ahmed M, Drouillard I, El-Kartouti A, Wey PF, Lions C, Martinez JY.

Ann Fr Anesth Reanim. 2007 Jan;26(1):74-6. Epub 2006 Dec 8. French.

PMID:
17158020
10.

Population pharmacokinetics of nefopam in elderly, with or without renal impairment, and its link to treatment response.

Djerada Z, Fournet-Fayard A, Gozalo C, Lelarge C, Lamiable D, Millart H, Malinovsky JM.

Br J Clin Pharmacol. 2014 Jun;77(6):1027-38. doi: 10.1111/bcp.12291.

12.

The effects of nefopam on the gain and maximum intensity of shivering in healthy volunteers.

Taniguchi Y, Ali SZ, Kimberger O, Zmoos S, Lauber R, Markstaller M, Kurz A.

Anesth Analg. 2010 Aug;111(2):409-14. doi: 10.1213/ANE.0b013e3181e332bb. Epub 2010 Jun 7.

PMID:
20529984
13.

Compartmental pharmacokinetics of nefopam during mild hypothermia.

Podranski T, Bouillon TW, Riva T, Kurz AM, Oehmke MJ.

Br J Anaesth. 2012 May;108(5):784-91. doi: 10.1093/bja/aer517. Epub 2012 Feb 13.

PMID:
22331396
14.

Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.

De Martin S, Orlando R, Bertoli M, Pegoraro P, Palatini P.

Clin Pharmacol Ther. 2006 Dec;80(6):597-606.

PMID:
17178261
15.

Two-stage analysis of pharmacokinetics of sufentanil administered by target-controlled infusion in Chinese patients.

Zhao Y, Duan JL, Wu XM, Jiang JY, Lu W, Zhang LP, Wang J, Meng XL, Xu CY, Jia DL, Liu W, Sheng XY.

Chin Med J (Engl). 2009 Sep 5;122(17):1979-84.

PMID:
19781381
16.

Fatal overdosage with nefopam (Acupan).

Tracqui A, Berthelon L, Ludes B.

J Anal Toxicol. 2002 May-Jun;26(4):239-43. Review.

PMID:
12054367
17.

Pharmacokinetics of bepridil and two of its metabolites in patients with end-stage renal disease.

Awni WM, Halstenson CE, Nayak RK, Opsahl JA, Desiraju RK, Minn FL, Matzke GR.

J Clin Pharmacol. 1995 Apr;35(4):379-83.

PMID:
7650227
18.

Levofloxacin pharmacokinetics in ESRD and removal by the cellulose acetate high performance-210 hemodialyzer.

Sowinski KM, Lucksiri A, Kays MB, Scott MK, Mueller BA, Hamburger RJ.

Am J Kidney Dis. 2003 Aug;42(2):342-9.

PMID:
12900817
19.

Propofol infusion for induction and maintenance of anaesthesia in patients with end-stage renal disease.

Ickx B, Cockshott ID, Barvais L, Byttebier G, De Pauw L, Vandesteene A, D'Hollander AA.

Br J Anaesth. 1998 Dec;81(6):854-60.

PMID:
10211008

Supplemental Content

Support Center